🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare 6-month treatment outcomes for 15-2...
Status
Completed
Location
Friends Research Institute
Start Date
2013-06
Trial ID
NCT01843023
Treatments Being Tested
This was a study of the effects of VIVITROL® on alcohol cue-induced craving...
Status
Completed
Location
McLean Hospital
Start Date
2007-07
Trial ID
NCT00511836
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of Me...
Status
Completed
Location
Alkermes Clinical Study Site
Start Date
2009-03
Trial ID
NCT00834080
Treatments Being Tested
This study is a phase IV, two-arm, randomized, double-blind, placebo-contro...
Status
Recruiting
Location
University of Pennsylvania Center for Studies of Addiction
Start Date
2022-03-07
Trial ID
NCT05028062
Treatments Being Tested
The Primary Objective of this study is to compare the effectiveness of HIV ...
Status
Completed
Location
Tarzana Treatment Centers
Start Date
2018-02-05
Trial ID
NCT03275350
Treatments Being Tested
Naltrexone is a medication that has been shown to help prevent relapse to o...
Status
Completed
Location
Rhode Island Hospital
Start Date
2012-03
Trial ID
NCT01563718
Treatments Being Tested
Persons dependent on opioids like heroin, morphine, or codeine have a high ...
Status
Completed
Location
Akershus University Hospital
Start Date
2012-10
Trial ID
NCT01717963
Treatments Being Tested
The specific aims of this pragmatic randomized controlled trial are to comp...
Status
Completed
Location
Boston Medical Center
Start Date
2016-06
Trial ID
NCT02478489
Treatments Being Tested
To evaluate the efficacy of VIVITROL (naltrexone for extended-release injec...
Status
Completed
Location
University of Pennsylvania
Start Date
2009-07
Trial ID
NCT00777062
Treatments Being Tested
This was a Phase 3, multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT01218958